HCPCS Level II
J7644
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram
Codes near J7644
These sit next to J7644 in the CMS Level II file. All J codes
- J7639Dornase alfa, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram
- J7640Formoterol, inhalation solution, compounded product, administered through dme, unit dose form, 12 micrograms
- J7641Flunisolide, inhalation solution, compounded product, administered through dme, unit dose, per milligram
- J7642Glycopyrrolate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
- J7643Glycopyrrolate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
- J7645Ipratropium bromide, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
- J7647Isoetharine hcl, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
- J7648Isoetharine hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per milligram
- J7649Isoetharine hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram
- J7650Isoetharine hcl, inhalation solution, compounded product, administered through dme, unit dose form, per milligram
NDC crosswalk
| NDC | Drug | Labeler | Billable units |
|---|---|---|---|
| 00378-7970-52 | Ipratropium Bromide | Mylan Pharmaceuticals Inc. | 13 |
| 00378-7970-55 | Ipratropium Bromide | Mylan Pharmaceuticals Inc. | 15 |
| 00378-7970-91 | Ipratropium Bromide | Mylan Pharmaceuticals Inc. | 30 |
| 00378-7970-93 | Ipratropium Bromide | Mylan Pharmaceuticals Inc. | 15 |
| 00487-9801-01 | Ipratropium Bromide | Nephron SC, Inc. | 15 |
| 00487-9801-25 | Ipratropium Bromide | Nephron SC, Inc. | 13 |
| 00487-9801-30 | Ipratropium Bromide | Nephron SC, Inc. | 15 |
| 00487-9801-60 | Ipratropium Bromide | Nephron SC, Inc. | 30 |
| 47335-0706-49 | Ipratropium Bromide | Sun Pharmaceutical Global FZE. | 13 |
| 47335-0706-52 | Ipratropium Bromide | Sun Pharmaceutical Global FZE. | 15 |
| 47335-0706-54 | Ipratropium Bromide | Sun Pharmaceutical Global FZE. | 30 |
| 50090-0668-00 | Ipratropium Bromide | A-S Medication Solutions | 13 |
| 50090-6373-00 | Ipratropium Bromide | A-S Medication Solutions | 13 |
| 60687-0394-83 | Ipratropium Bromide | American Health Packaging | 15 |
| 62135-0830-84 | Ipratropium Bromide | Chartwell | 15 |
| 64980-0640-02 | Ipratropium Bromide | Rising Pharma Holdings, Inc. | 13 |
| 64980-0640-03 | Ipratropium Bromide | Rising Pharma Holdings, Inc. | 15 |
| 64980-0640-06 | Ipratropium Bromide | Rising Pharma Holdings, Inc. | 30 |
| 76204-0100-01 | Ipratropium Bromide | Ritedose Pharmaceuticals, LLC | 15 |
| 76204-0100-25 | Ipratropium Bromide | Ritedose Pharmaceuticals, LLC | 13 |
| 76204-0100-30 | Ipratropium Bromide | Ritedose Pharmaceuticals, LLC | 15 |
| 76204-0100-60 | Ipratropium Bromide | Ritedose Pharmaceuticals, LLC | 30 |
Source: CMS ASP NDC-HCPCS crosswalk, effective October 1, 2026 through December 31, 2026.